torecan coated tablets 6.33 base milligrams
novartis pharmaceuticals uk ltd - coated tablets - 6.33 base milligrams
torecan suppositories 6.5 milligram
novartis pharmaceuticals uk ltd - thiethylperazine maleate - suppositories - 6.5 milligram
torecan solution for injection 6.5 mg/ml
novartis pharmaceuticals uk ltd - thiethylperazine maleate - solution for injection - 6.5 mg/ml
torecan
novartis new zealand ltd - thiethylperazine maleate 6.5 mg/ml - solution for injection - 6.5 mg/ml - active: thiethylperazine maleate 6.5 mg/ml
cefditoren pivoxil tablet, film coated
pharma romlev inc. - cefditoren pivoxil (unii: 78tha212dh) (cefditoren - unii:81qs09v3yw) - cefditoren 200 mg - cefditoren pivoxil is indicated for the treatment of mild to moderate infections in adults and adolescents (12 years of age or older) which are caused by susceptible strains of the designated microorganisms in the conditions listed below. acute bacterial exacerbation of chronic bronchitis caused by haemophilus influenzae (including ß-lactamase-producing strains), haemophilus parainfluenzae (including ß-lactamase producing strains), streptococcus pneumoniae (penicillin susceptible strains only), or moraxella catarrhalis (including ß-lactamase-producing strains). community-acquired pneumonia caused by haemophilus influenzae (including ß-lactamase-producing strains), haemophilus parainfluenzae (including ß-lactamase-producing strains), streptococcus pneumoniae (penicillin-susceptible strains only), or moraxella catarrhalis (including ß-lactamase producing strains). pharyngitis/tonsillitis caused by streptococcus pyogenes . note: cefditoren pivoxil is effective in the eradication of streptococcus pyoge
spectracef- cefditoren pivoxil tablet, film coated spectracef- cefditoren pivoxil tablet, film coated
vansen pharma inc. - cefditoren pivoxil (unii: 78tha212dh) (cefditoren - unii:81qs09v3yw) - cefditoren 200 mg - spectracef® (cefditoren pivoxil) is indicated for the treatment of mild to moderate infections in adults and adolescents (12 years of age or older) which are caused by susceptible strains of the designated microorganisms in the conditions listed below. acute bacterial exacerbation of chronic bronchitis caused by haemophilus influenzae (including ß-lactamase-producing strains), haemophilus parainfluenzae (including ß-lactamase producing strains), streptococcus pneumoniae (penicillin susceptible strains only), or moraxella catarrhalis (including ß-lactamase-producing strains). community-acquired pneumonia caused by haemophilus influenzae (including ß-lactamase-producing strains), haemophilus parainfluenzae (including ß-lactamase-producing strains), streptococcus pneumoniae (penicillin-susceptible strains only), or moraxella catarrhalis (including ß-lactamase producing strains). pharyngitis/tonsillitis caused by streptococcus pyogenes . note: spectracef® is effective in the eradication of streptococcu
korean red ginseng tablets
korean ginseng corporation - korea, korea - tablet - 300 mg - korean red ginseng powder (100%)
korean red ginseng powder capsule
korean ginseng corporation - korea, korea - capsule - 500 mg - korean red ginseng powder (100%)
cefditoren pivoxil fine granules for pediatric 10% "towa" (セフジトレンピボキシル細粒小児用10%「トーワ」)
towa pharmaceutical co., ltd. - cefditoren pivoxil - orange fine granules
cefditoren pivoxil fine granules 10% for pediatric "ok" (セフジトレンピボキシル小児用細粒10%「ok」)
meiji seika pharma co., ltd. - cefditoren pivoxil - orange fine granules